Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial

References

• The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf200752759217508116
   PubMed Web of Science ®Google Scholar
• The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)Ocul Surf2007529310717508117
   PubMed Web of Science ®Google Scholar
• MiljanovićBDanaRSullivanDASchaumbergDAImpact of dry eye syndrome on vision-related quality of lifeAm J Ophthalmol2007143340941517317388
   PubMed Web of Science ®Google Scholar
• MarketScopeLLC2013Comprehensive Report on the Global Dry Eye Products Market Available from: http://market-scope.com/products-page/other-reports/2013-comprehensive-report-on-the-global-dry-eye-market/Accessed February 1, 2013
   Google Scholar
• BehrensADoyleJJSternLthe Dysfunctional Tear Syndrome Study GroupDysfunctional tear syndrome: a Delphi approach to treatment recommendationsCornea200625890090717102664
   PubMed Web of Science ®Google Scholar
• GreneRBLankstonPMordauntJHarroldMGwonAJonesRUnpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis siccaCornea19921142943011424648
   PubMed Web of Science ®Google Scholar
• SimmonsPAVehigeJGClinical performance of a mid-viscosity artificial tear for dry eye treatmentCornea200726329430217413956
   PubMed Web of Science ®Google Scholar
• GarrettQSimmonsPAXuSCarboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healingInvest Ophthalmol Vis Sci20074841559156717389485
   PubMed Web of Science ®Google Scholar
• NapoliPECoronellaFSattaGMZuccaIAFossarelloMA novel OCT technique to measure in vivo the corneal adhesiveness for sodium carboxymethylcellulose in humans and its validity in the diagnosis of dry eyeInvest Ophthalmol Vis Sci20145553179318524764061
   PubMed Web of Science ®Google Scholar
• GarrettQXuSSimmonsPACarboxymethyl cellulose stimulates rabbit corneal epithelial wound healingCurr Eye Res200833756757318600489
   PubMed Web of Science ®Google Scholar
• PaughJRNguyenALKetelsonHAChristensenMTMeadowsDLPrecorneal residence time of artificial tears measured in dry eye subjectsOptom Vis Sci200885872573118677236
   PubMed Web of Science ®Google Scholar
• NapoliPESattaGMCoronellaFFossarelloMSpectral-domain optical coherence tomography study on dynamic changes of human tears after instillation of artificial tearsInvest Ophthalmol Vis Sci20145574533454024985473
   PubMed Web of Science ®Google Scholar
• BaudouinCAragonaPMessmerEMRole of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meetingOcul Surf201311424625824112228
   PubMed Web of Science ®Google Scholar
• StahlUWillcoxMStapletonFOsmolality and tear film dynamicsClin Exp Optom201295131122022802
   PubMed Web of Science ®Google Scholar
• PflugfelderSCCorralesRMde PaivaCST helper cytokines in dry eye diseaseExp Eye Res201311711812524012834
   PubMed Web of Science ®Google Scholar
• StevensonWChauhanSKDanaRDry eye disease: an immune-mediated ocular surface disorderArch Ophthalmol201213019010022232476
   PubMedGoogle Scholar
• GomesJAAmankwahRPowell-RichardsADuaHSSodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitroBr J Ophthalmol200488682182515148219
   PubMed Web of Science ®Google Scholar
• BaeyensVBronABaudouinCEfficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye diseaseJ Fr Ophtalmol201235641241922483761
   PubMed Web of Science ®Google Scholar
• BaudouinCCochenerBPisellaPJRandomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye diseaseEur J Ophthalmol201222575176122287172
   PubMed Web of Science ®Google Scholar
• VogelRCrockettRSOdenNLaliberteTWMolinaLDemonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)Am J Ophthalmol2010149459460120346777
   PubMed Web of Science ®Google Scholar
• SimmonsPABeardBJVehigeJGOptimizing viscosity of ophthalmic solutions with the combination of two polymers Available from: http://www.tfos2013.org/program.htmlAccessed December 20, 2013
   Google Scholar
• De PaivaCSCorralesRMVillarrealALCorticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eyeExp Eye Res200683352653516643899
   PubMed Web of Science ®Google Scholar
• CorralesRMLuoLChangEYPflugfelderSCEffects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cellsCornea200827557457918520508
   PubMed Web of Science ®Google Scholar
• SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the ocular surface disease indexArch Ophthalmol2000118561562110815152
   PubMedGoogle Scholar
• KorbDRGreinerJVHermanJComparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) methodCornea200120881181511685057
   PubMed Web of Science ®Google Scholar
• De PaivaCSPflugfelderSCCorneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulationAm J Ophthalmol2004137110911514700652
   PubMed Web of Science ®Google Scholar
• LeggeGERossJALuebkerALaMayJMPsychophysics of reading. VIII. The Minnesota low-vision reading testOptom Vis Sci198966128438532626251
   PubMed Web of Science ®Google Scholar
• MillerKLWaltJGMinkDRMinimal clinically important difference for the ocular surface disease indexArch Ophthalmol201012819410120065224
   PubMedGoogle Scholar
• Le HenanffAGiraudeauBBaronGRavaudPQuality of reporting of noninferiority and equivalence randomized trialsJAMA2006295101147115116522835
   PubMed Web of Science ®Google Scholar
• ZhengXGotoTOhashiYComparison of in vivo efficacy of different ocular lubricants in dry eye animal modelsInvest Ophthalmol Vis Sci20145563454346024781937
   PubMed Web of Science ®Google Scholar
• ZhengXGotoTShiraishiAOhashiYIn vitro efficacy of ocular surface lubricants against dehydrationCornea20133291260126423860431
   PubMed Web of Science ®Google Scholar
• CondonPIMcEwenCGWrightMMackintoshGPrescottRJMcDonaldCDouble blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndromeBr J Ophthalmol199983101121112410502570
   PubMed Web of Science ®Google Scholar
• McDonaldCCKayeSBFigueiredoFCMacintoshGLockettCA randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndromeEye (Lond)200216560160712194076
   PubMed Web of Science ®Google Scholar
• AragonaPPapaVMicaliASantoconoMMilazzoGLong term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eyeBr J Ophthalmol200286218118411815344
   PubMed Web of Science ®Google Scholar
• YokoiNKomuroANishidaKKinoshitaSEffectiveness of hyaluronan on corneal epithelial barrier function in dry eyeBr J Ophthalmol19978175335369290362
   PubMed Web of Science ®Google Scholar
• LentonLMAlbietzJMEffect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusisJ Refract Surg1999152 SupplS227S23110202728
   PubMed Web of Science ®Google Scholar
• AlbietzJMLentonLMMcLennanSGEarlMLA comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patientsCLAO J20022829610012054380
   PubMedGoogle Scholar
• NilforoushanMRLatkanyRASpeakerMGEffect of artificial tears on visual acuityAm J Ophthalmol2005140583083516310460
   PubMed Web of Science ®Google Scholar
• MonacoGCacioppoVConsonniDTroianoPEffects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapyEur J Ophthalmol201121324325020872359
   PubMed Web of Science ®Google Scholar
• LeeJHAhnHSKimEKKimTIEfficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye diseaseCornea201130217517921045674
   PubMed Web of Science ®Google Scholar
• GuillonMMaissaCHoSEvaluation of the effects on conjunctival tissues of Optive eyedrops over one month usageCont Lens Anterior Eye2010332939920227636
   PubMed Web of Science ®Google Scholar
• SanchezMATorralbo-JimenezPGironNComparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric studyCornea201029216717120023577
   PubMed Web of Science ®Google Scholar
• BrignoleFPisellaPJDupasBBaeyensVBaudouinCEfficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitisGraefes Arch Clin Exp Ophthalmol2005243653153815965673
   PubMed Web of Science ®Google Scholar
• NapoliPECoronellaFSattaGMFossarelloMA novel technique of contrast-enhanced optical coherence tomography imaging in evaluation of clearance of lipids in human tearsPLoS One2014911e10984325369027
   PubMed Web of Science ®Google Scholar